Potential psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene analogs.
D000588:Amines / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001966:Bromine / Q000494:pharmacology; D004193:Discrimination Learning / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006213:Hallucinogens / Q000138:chemical synthesis* / Q000494:pharmacology; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009281:Naphthalenes / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship
D000588:Amines; D006213:Hallucinogens; D009281:Naphthalenes; D011955:Receptors, Drug; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D001966:Bromine